Medication
1.0.0 - STU1

This page is part of the HL7 Belgium FHIR Implementation Guide - Medication profiles (v1.0.0: Trial Use) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Medicationrecord Requirements

Requirements:

  Requirement
R1 Medication information may include detailed process information (e.g. prescriptions and dispenses, with detailed traceability information), or summary information such as that reported by a patient or by a GP.
R2 Medication information may be processed, for example aggregated, reconciled, etc. and this should be exchanged transparently
R3 The aggregation of medication information may be done differently, with different rules
For example, medications may be aggregated by the active principle, or by active principle and indication for a more granular view
R4 A prescription may be triggered by first defining and planning a treatment plan, or the treatment may be documented after a prescription or dispense.
R5 In different parts of the process, Medication may be represented differently
For example, a medication is prescribed by its active principle, and a branded product is dispensed.
R6 Medication items can have a M:N relation type with indications
R7 Medication overviews may include different types of medication
for example, some overviews may include vaccines, anesthetics, and OTPs, while others may exclude some of these.
R8 Medication overviews may include different periods
For example, some overviews may include only the recent medication, while others may include the patient’s lifelong medication information
R9 The way that medication information is exchanged should capture the meaning of the information (e.g. whether the information is a prescription or a paient-reported summary),
R10 The medication exchange information should reflect the status, (e.g. from planned vs ongoing), but should be exchanged in a consistent way across the status
For example, a medication that is planned but not yet prescribed should be summarized in a way that is consistent when it is prescribed, or reported by the patient